Influence of thymidylate synthase DNA polymorphisms and gender on the clinical evolution of patients with advanced colorectal cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Oncology Report

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR_00000776PMID 20372856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.

  2009cited by this paper
• Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer.

  2008cited by this paper
• Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas

  2007cited by this paper
• Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria

  2007cited by this paper
• G>C SNP of thymidylate synthase with respect to colorectal cancer.

  2007cited by this paper
• Thymidylate synthase polymorphisms and colon cancer: Associations with tumor stage, tumor characteristics and survival

  2007cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Differential Stability of Thymidylate Synthase 3′-Untranslated Region Polymorphic Variants Regulated by AUF1*

  2006cited by this paper
• Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.

  2006cited by this paper
• Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis

  2006cited by this paper
• Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil.

  2006cited by this paper
• Prognostic Role of Thymidylate Synthase Polymorphisms in Gastric Cancer Patients Treated with Surgery and Adjuvant Chemotherapy

  2005cited by this paper
• Polymorphisms in the Reduced Folate Carrier, Thymidylate Synthase, or Methionine Synthase and Risk of Colon Cancer

  2005cited by this paper
• Predictive markers in breast and other cancers: a review.

  2005cited by this paper
• ERβ isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates

  2005cited by this paper
• Thymidylate synthase pharmacogenetics

  2005cited by this paper
• Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based Chemotherapy

  2004cited by this paper
• Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil‐based chemotherapy in advanced colorectal cancer patients

  2004cited by this paper
• Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.

  2004cited by this paper
• Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues.

  2004cited by this paper
• A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels.

  2004cited by this paper
• Activity Gene Abolishes USF-1 Binding and Alters Transcriptional Thymidylate Synthase Tandem Repeat Polymorphism of the ′ A Novel Single Nucleotide Polymorphism within the 5

  2003cited by this paper
• Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer.

  2003cited by this paper
• Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.

  2003cited by this paper
• Genetic Data Analysis II. Methods for Discrete Population Genentic Data

  2002cited by this paper
• Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.

  2001cited by this paper
• Selective loss of estrogen receptor beta in malignant human colon.

  2000cited by this paper
• Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene.

  2000cited by this paper
• Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.

  2000cited by this paper
• Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system.

  2000cited by this paper
• Estrogen replacement therapy and colorectal cancer risk in elderly women

  1999cited by this paper
• Thymidylate Synthase: A Target for Combination Therapy and Determinant of Chemotherapeutic Response in Colorectal Cancer

  1999cited by this paper
• Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis.

  1999cited by this paper
• Cloning and characterization of human estrogen receptor beta isoforms.

  1998cited by this paper
• Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase.

  1995cited by this paper
• Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women.

  1995cited by this paper
• Gender and colorectal cancer.

  1993cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers

  2022cites this paper
• Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine based chemotherapy toxicity.

  2021cites this paper
• Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.

  2017cites this paper
• Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.

  2015cites this paper
• Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy

  2013cites this paper
• An integrated analysis of the association between Ts gene polymorphisms and clinical outcome in gastric and colorectal cancer patients treated with 5-FU-based regimens

  2013cites this paper
• Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines

  2013cites this paper
• Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer.

  2012cites this paper
• Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Meta-Analysis of Colorectal Cancer Survival Data

  2012cites this paper
• Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis

  2012cites this paper
• Association of Thymidylate Synthase and Hypoxia Inducible Factor-1alpha DNA Polymorphisms with Pancreatic Cancer

  2012cites this paper
• UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.

  2012cites this paper
• The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer.

  2011cites this paper